Clinical evaluation of a resurfacing device implant for femoral osteochondral defects greater than 1 cm2 with a minimal follow-up of 4 years: a prospective cohort study
Purpose Osteochondral defects have a limited capacity to heal and can evolve to an early osteoarthritis. A surgical possibility is the replacement of the affected cartilaginous area with a resurfacing device BioPoly™ RS Partial Resurfacing Knee Implant. The aim of this study was to report the clinic...
Gespeichert in:
| Veröffentlicht in: | European journal of orthopaedic surgery & traumatology 2023-12, Vol.33 (8), p.3693-3701 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 3701 |
|---|---|
| container_issue | 8 |
| container_start_page | 3693 |
| container_title | European journal of orthopaedic surgery & traumatology |
| container_volume | 33 |
| creator | Bouché, Pierre-Alban Fiodière, Valerian Kierszbaum, Elliott Ehkirch, François-Paul |
| description | Purpose
Osteochondral defects have a limited capacity to heal and can evolve to an early osteoarthritis. A surgical possibility is the replacement of the affected cartilaginous area with a resurfacing device BioPoly™ RS Partial Resurfacing Knee Implant. The aim of this study was to report the clinical and survival outcomes of the BioPoly™ after a minimum follow-up of 4 years.
Methods
This study included all patients who had a BioPoly™ for femoral osteochondral defects greater than 1 cm
2
and at least ICRS grade 2. The main outcome was to observe the KOOS and the Tegner activity score were used to assess outcomes preoperatively and at the last follow-up. The secondary outcomes were the VAS for pain, the complications rate post-surgery and survival rate of BioPoly™ at the last FU.
Results
Eighteen patients with 44.4% (8/18) of women were included with a mean age of 46.6 years (11.4), a mean body mass index (BMI) of 21.5 (kg/m
2
) (2.3). The mean follow-up was 6.3 years (1.3). We found a significant difference comparing pre-operative KOOS score and at last follow-up [respectively, 66.56(14.37) vs 84.17(7.656),
p
|
| doi_str_mv | 10.1007/s00590-023-03613-y |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2824690947</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2824690947</sourcerecordid><originalsourceid>FETCH-LOGICAL-c282t-ec1801fa96e33ab54778a1d0a92b9527457ba138f4b4bd7f1e5d31f6bf5d6d563</originalsourceid><addsrcrecordid>eNp9kc1O3DAUhaMKJGDgBVhZ6qabFDuO89NdNYKChNRNWVuOfT3jURKntjMob8O6j8GT9Q5TqVUXrHwtfefcn5Nl14x-ZpTWN5FS0dKcFjynvGI8Xz5k56zkRc5o1Zz8U59lFzHuKGWiZeI8-7Xu3ei06gnsVT-r5PxIvCWKBIhzsEq7cUMM7J0G4oapV2Mi1gdiYfABZT4m8HrrR3P4GbCgUySbACpBIGmrRsJeX_RQkGeXtug7YL8BUev73j_n83RoV76-LKBC_ILAFHyc0MXtgWi_9SGRmGazXGanVvURrv68q-zp7vbH-j5__P7tYf31MddFU6QcNGsos6qtgHPVibKuG8UMVW3RtaKoS1F3ivHGll3ZmdoyEIYzW3VWmMqIiq-yT0dfHOTnDDHJwUUNPa4Ofo4Su5RVS9uyRvTjf-jOz2HE6ZBq8cYNXhyp4khp3CwGsHIKeIKwSEblIT55jE9ifPItPrmgiB9FEeFxA-Gv9Tuq3zdzolE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2890158068</pqid></control><display><type>article</type><title>Clinical evaluation of a resurfacing device implant for femoral osteochondral defects greater than 1 cm2 with a minimal follow-up of 4 years: a prospective cohort study</title><source>Springer Nature - Complete Springer Journals</source><creator>Bouché, Pierre-Alban ; Fiodière, Valerian ; Kierszbaum, Elliott ; Ehkirch, François-Paul</creator><creatorcontrib>Bouché, Pierre-Alban ; Fiodière, Valerian ; Kierszbaum, Elliott ; Ehkirch, François-Paul</creatorcontrib><description>Purpose
Osteochondral defects have a limited capacity to heal and can evolve to an early osteoarthritis. A surgical possibility is the replacement of the affected cartilaginous area with a resurfacing device BioPoly™ RS Partial Resurfacing Knee Implant. The aim of this study was to report the clinical and survival outcomes of the BioPoly™ after a minimum follow-up of 4 years.
Methods
This study included all patients who had a BioPoly™ for femoral osteochondral defects greater than 1 cm
2
and at least ICRS grade 2. The main outcome was to observe the KOOS and the Tegner activity score were used to assess outcomes preoperatively and at the last follow-up. The secondary outcomes were the VAS for pain, the complications rate post-surgery and survival rate of BioPoly™ at the last FU.
Results
Eighteen patients with 44.4% (8/18) of women were included with a mean age of 46.6 years (11.4), a mean body mass index (BMI) of 21.5 (kg/m
2
) (2.3). The mean follow-up was 6.3 years (1.3). We found a significant difference comparing pre-operative KOOS score and at last follow-up [respectively, 66.56(14.37) vs 84.17(7.656),
p
< 0.01]. At last follow-up, the Tegner score was different [respectively, 3.05(1.3) vs 3.6(1.3),
p
< 0.01]. At 5 years, the survival rate was of 94.7%.
Conclusions
BioPoly™ is a real alternative for femoral osteochondral defects greater than 1 cm
2
and at least ICRS grade 2. It will be interesting to compare this implant to mosaicplasty technic and/or microfracture at 5 years postoperatively regarding clinical outcomes and survival rate.
Level of evidence
Therapeutic level III. Prospective cohort study.</description><identifier>ISSN: 1432-1068</identifier><identifier>ISSN: 1633-8065</identifier><identifier>EISSN: 1432-1068</identifier><identifier>DOI: 10.1007/s00590-023-03613-y</identifier><language>eng</language><publisher>Paris: Springer Paris</publisher><subject>Cohort analysis ; Medicine ; Medicine & Public Health ; Original Article ; Surgical Orthopedics ; Traumatic Surgery</subject><ispartof>European journal of orthopaedic surgery & traumatology, 2023-12, Vol.33 (8), p.3693-3701</ispartof><rights>The Author(s), under exclusive licence to Springer-Verlag France SAS, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c282t-ec1801fa96e33ab54778a1d0a92b9527457ba138f4b4bd7f1e5d31f6bf5d6d563</citedby><cites>FETCH-LOGICAL-c282t-ec1801fa96e33ab54778a1d0a92b9527457ba138f4b4bd7f1e5d31f6bf5d6d563</cites><orcidid>0000-0002-4117-4651</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00590-023-03613-y$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00590-023-03613-y$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids></links><search><creatorcontrib>Bouché, Pierre-Alban</creatorcontrib><creatorcontrib>Fiodière, Valerian</creatorcontrib><creatorcontrib>Kierszbaum, Elliott</creatorcontrib><creatorcontrib>Ehkirch, François-Paul</creatorcontrib><title>Clinical evaluation of a resurfacing device implant for femoral osteochondral defects greater than 1 cm2 with a minimal follow-up of 4 years: a prospective cohort study</title><title>European journal of orthopaedic surgery & traumatology</title><addtitle>Eur J Orthop Surg Traumatol</addtitle><description>Purpose
Osteochondral defects have a limited capacity to heal and can evolve to an early osteoarthritis. A surgical possibility is the replacement of the affected cartilaginous area with a resurfacing device BioPoly™ RS Partial Resurfacing Knee Implant. The aim of this study was to report the clinical and survival outcomes of the BioPoly™ after a minimum follow-up of 4 years.
Methods
This study included all patients who had a BioPoly™ for femoral osteochondral defects greater than 1 cm
2
and at least ICRS grade 2. The main outcome was to observe the KOOS and the Tegner activity score were used to assess outcomes preoperatively and at the last follow-up. The secondary outcomes were the VAS for pain, the complications rate post-surgery and survival rate of BioPoly™ at the last FU.
Results
Eighteen patients with 44.4% (8/18) of women were included with a mean age of 46.6 years (11.4), a mean body mass index (BMI) of 21.5 (kg/m
2
) (2.3). The mean follow-up was 6.3 years (1.3). We found a significant difference comparing pre-operative KOOS score and at last follow-up [respectively, 66.56(14.37) vs 84.17(7.656),
p
< 0.01]. At last follow-up, the Tegner score was different [respectively, 3.05(1.3) vs 3.6(1.3),
p
< 0.01]. At 5 years, the survival rate was of 94.7%.
Conclusions
BioPoly™ is a real alternative for femoral osteochondral defects greater than 1 cm
2
and at least ICRS grade 2. It will be interesting to compare this implant to mosaicplasty technic and/or microfracture at 5 years postoperatively regarding clinical outcomes and survival rate.
Level of evidence
Therapeutic level III. Prospective cohort study.</description><subject>Cohort analysis</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Original Article</subject><subject>Surgical Orthopedics</subject><subject>Traumatic Surgery</subject><issn>1432-1068</issn><issn>1633-8065</issn><issn>1432-1068</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNp9kc1O3DAUhaMKJGDgBVhZ6qabFDuO89NdNYKChNRNWVuOfT3jURKntjMob8O6j8GT9Q5TqVUXrHwtfefcn5Nl14x-ZpTWN5FS0dKcFjynvGI8Xz5k56zkRc5o1Zz8U59lFzHuKGWiZeI8-7Xu3ei06gnsVT-r5PxIvCWKBIhzsEq7cUMM7J0G4oapV2Mi1gdiYfABZT4m8HrrR3P4GbCgUySbACpBIGmrRsJeX_RQkGeXtug7YL8BUev73j_n83RoV76-LKBC_ILAFHyc0MXtgWi_9SGRmGazXGanVvURrv68q-zp7vbH-j5__P7tYf31MddFU6QcNGsos6qtgHPVibKuG8UMVW3RtaKoS1F3ivHGll3ZmdoyEIYzW3VWmMqIiq-yT0dfHOTnDDHJwUUNPa4Ofo4Su5RVS9uyRvTjf-jOz2HE6ZBq8cYNXhyp4khp3CwGsHIKeIKwSEblIT55jE9ifPItPrmgiB9FEeFxA-Gv9Tuq3zdzolE</recordid><startdate>20231201</startdate><enddate>20231201</enddate><creator>Bouché, Pierre-Alban</creator><creator>Fiodière, Valerian</creator><creator>Kierszbaum, Elliott</creator><creator>Ehkirch, François-Paul</creator><general>Springer Paris</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-4117-4651</orcidid></search><sort><creationdate>20231201</creationdate><title>Clinical evaluation of a resurfacing device implant for femoral osteochondral defects greater than 1 cm2 with a minimal follow-up of 4 years: a prospective cohort study</title><author>Bouché, Pierre-Alban ; Fiodière, Valerian ; Kierszbaum, Elliott ; Ehkirch, François-Paul</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c282t-ec1801fa96e33ab54778a1d0a92b9527457ba138f4b4bd7f1e5d31f6bf5d6d563</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Cohort analysis</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Original Article</topic><topic>Surgical Orthopedics</topic><topic>Traumatic Surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bouché, Pierre-Alban</creatorcontrib><creatorcontrib>Fiodière, Valerian</creatorcontrib><creatorcontrib>Kierszbaum, Elliott</creatorcontrib><creatorcontrib>Ehkirch, François-Paul</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Proquest Nursing & Allied Health Source</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of orthopaedic surgery & traumatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bouché, Pierre-Alban</au><au>Fiodière, Valerian</au><au>Kierszbaum, Elliott</au><au>Ehkirch, François-Paul</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical evaluation of a resurfacing device implant for femoral osteochondral defects greater than 1 cm2 with a minimal follow-up of 4 years: a prospective cohort study</atitle><jtitle>European journal of orthopaedic surgery & traumatology</jtitle><stitle>Eur J Orthop Surg Traumatol</stitle><date>2023-12-01</date><risdate>2023</risdate><volume>33</volume><issue>8</issue><spage>3693</spage><epage>3701</epage><pages>3693-3701</pages><issn>1432-1068</issn><issn>1633-8065</issn><eissn>1432-1068</eissn><abstract>Purpose
Osteochondral defects have a limited capacity to heal and can evolve to an early osteoarthritis. A surgical possibility is the replacement of the affected cartilaginous area with a resurfacing device BioPoly™ RS Partial Resurfacing Knee Implant. The aim of this study was to report the clinical and survival outcomes of the BioPoly™ after a minimum follow-up of 4 years.
Methods
This study included all patients who had a BioPoly™ for femoral osteochondral defects greater than 1 cm
2
and at least ICRS grade 2. The main outcome was to observe the KOOS and the Tegner activity score were used to assess outcomes preoperatively and at the last follow-up. The secondary outcomes were the VAS for pain, the complications rate post-surgery and survival rate of BioPoly™ at the last FU.
Results
Eighteen patients with 44.4% (8/18) of women were included with a mean age of 46.6 years (11.4), a mean body mass index (BMI) of 21.5 (kg/m
2
) (2.3). The mean follow-up was 6.3 years (1.3). We found a significant difference comparing pre-operative KOOS score and at last follow-up [respectively, 66.56(14.37) vs 84.17(7.656),
p
< 0.01]. At last follow-up, the Tegner score was different [respectively, 3.05(1.3) vs 3.6(1.3),
p
< 0.01]. At 5 years, the survival rate was of 94.7%.
Conclusions
BioPoly™ is a real alternative for femoral osteochondral defects greater than 1 cm
2
and at least ICRS grade 2. It will be interesting to compare this implant to mosaicplasty technic and/or microfracture at 5 years postoperatively regarding clinical outcomes and survival rate.
Level of evidence
Therapeutic level III. Prospective cohort study.</abstract><cop>Paris</cop><pub>Springer Paris</pub><doi>10.1007/s00590-023-03613-y</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-4117-4651</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1432-1068 |
| ispartof | European journal of orthopaedic surgery & traumatology, 2023-12, Vol.33 (8), p.3693-3701 |
| issn | 1432-1068 1633-8065 1432-1068 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2824690947 |
| source | Springer Nature - Complete Springer Journals |
| subjects | Cohort analysis Medicine Medicine & Public Health Original Article Surgical Orthopedics Traumatic Surgery |
| title | Clinical evaluation of a resurfacing device implant for femoral osteochondral defects greater than 1 cm2 with a minimal follow-up of 4 years: a prospective cohort study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T08%3A16%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20evaluation%20of%20a%20resurfacing%20device%20implant%20for%20femoral%20osteochondral%20defects%20greater%20than%201%C2%A0cm2%20with%20a%20minimal%20follow-up%20of%204%C2%A0years:%20a%20prospective%20cohort%20study&rft.jtitle=European%20journal%20of%20orthopaedic%20surgery%20&%20traumatology&rft.au=Bouch%C3%A9,%20Pierre-Alban&rft.date=2023-12-01&rft.volume=33&rft.issue=8&rft.spage=3693&rft.epage=3701&rft.pages=3693-3701&rft.issn=1432-1068&rft.eissn=1432-1068&rft_id=info:doi/10.1007/s00590-023-03613-y&rft_dat=%3Cproquest_cross%3E2824690947%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2890158068&rft_id=info:pmid/&rfr_iscdi=true |